AIV Logo AIV Assistant

Loading...

Logo Medifast, Inc. - MED Open Medifast, Inc. in new tab

11.80 USD
P/E
36.42
EPS
0.33
P/B
0.57
ROE
1.73
Beta
0.88
Medifast, Inc. logo

Medifast, Inc.

🧾 Earnings Recap – Q3 2025

Medifast's third-quarter results for 2025 showcased a strategic shift towards a holistic approach to metabolic health, reinforcing its commitment to long-term wellness solutions while navigating changes in the weight loss industry.

  • Achieved 16-week clinical results showing clients retained 98% of lean mass and reduced visceral fat by 14%, underscoring the effectiveness of its metabolic health programs.
  • Expanded insights with 61% of coaches assisting clients using GLP-1 medications, highlighting the integration of medication knowledge into client support.
  • Announced plans for innovative product launches incorporating next-generation ingredients targeting metabolic enhancement, set to hit the market next year.
  • Transitioning brand perception from a weight loss company to a broader leader in metabolic health, targeting a more expansive and durable market.
📅

11.8000 USD

11.800 USD

Daily: -3.12%
Key Metrics

Earnings date: Feb. 17, 2026

P/E: 36.42

EPS: 0.33

Book Value: 21.04

Price to Book: 0.57

Debt/Equity: 6.05

% Insiders: 3.203%

Growth

Revenue Growth: -0.37%

Earnings Growth: -0.95%

Estimates

Forward P/E: 40.07

Forward EPS: 0.30

DCF Valuation

Tweak assumptions to recompute fair value for Medifast, Inc. (MED)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Logo About Medifast, Inc. - (MED)

Country: United States

Sector: Consumer Discretionary

Website: http://medifastinc.com

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Exchange Ticker
LSE (United Kingdom) 0K05.L
FRA (Germany) MDF.F
MEX (Mexico) MED.MX
MCE (Spain) MDF.MC
NYQ (United States) MED
Historical Dividends
Year Total Dividends
2023 6.59 USD
2022 6.34 USD
2021 5.39 USD
2020 4.52 USD
2019 3.00 USD
2018 1.92 USD
2017 1.28 USD
2016 1.00 USD

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion